NCCN Guidelines for Patients
Acute Lymphoblastic Leukemia, Version 1.2017
Part 5 is a guide through the treatment
options for patients with ALL. However,
these treatments may also be used for
patients with lymphoblastic lymphoma.
This information is taken from the treatment
guidelines written by NCCN experts of ALL. These
treatment guidelines list options for people with ALL
in general. Your doctors may suggest other treatment
for you based on your health and personal needs.
Discuss and decide on your treatment options with
NCCN experts recommend that all patients
receive treatment in a specialized cancer center
with expertise and experience in ALL.
treatment of ALL is very complex. It’s important to
be cared for by a multidisciplinary team of experts
with experience in treating patients your age. Access
to clinical trials is also a chief priority. Specialized
cancer centers, such as large academic centers,
have the experts, experience, and research to
provide the best care for patients with ALL.
There are multiple treatment options for ALL.
Treatment options that are best for you depend on a
number of factors. This includes the features of the
cancer, such as the cytogenetic subtype, as well as
your age and health status.
The treatment options in Part 5 are grouped by
patient age and presence of the Philadelphia
chromosome. The type and intensity of treatment
differs based on your age and health. To plan
treatment, doctors put patients into two main age
The AYA group includes patients who are 15 to 39
years of age. The older adult group includes patients
who are 40 years of age or older. The other main
factors that affect treatment planning and options are
described in Part 3 on page 26.